Impact of a Mediterranean diet on quality of life for multiple sclerosis patients
The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients
This study is testing if following a Mediterranean diet can help improve the quality of life for people with multiple sclerosis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 140 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Tel-Aviv Sourasky Medical Center Government |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Tel Aviv, Israel) |
| Trial ID | NCT06764563 on ClinicalTrials.gov |
What this trial studies
This study investigates how following a Mediterranean diet may improve the quality of life for patients with multiple sclerosis (MS). It is a randomized controlled trial that aims to provide empirical evidence on the effects of dietary interventions, specifically the Mediterranean diet, on MS symptoms and overall well-being. The study will include patients with confirmed MS who have been on a stable medication regimen for at least six months. By comparing the quality of life outcomes between those adhering to the Mediterranean diet and a control group, the study seeks to clarify the potential benefits of this dietary approach for MS patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults with confirmed multiple sclerosis who have been stable on their medication for the past six months.
Not a fit: Patients who are pregnant, have gastrointestinal issues, or have serious liver dysfunction may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide evidence-based dietary recommendations that enhance the quality of life for patients with multiple sclerosis.
How similar studies have performed: While some studies suggest dietary interventions may benefit MS patients, this specific approach using the Mediterranean diet is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed MS based on 2017 Mcdonald criteria, with stable medication regimen in the previous six months. Exclusion Criteria: * Pregnancy or lactating * People with a lack of judgment * Serum creatinine ≥2 mg/dL(177 μmol per liter) or more * Patients who had gastrointestinal problems that would prevent them from following any of the test diets * Patients who had liver dysfunction (an increase by a factor of at least two above the upper limit of normal in alanine aminotransferase and aspartate aminotransferase levels) * Active cancer or chemotherapy treatment in the last three years.
Where this trial is running
Tel Aviv, Israel
- Tel Aviv Sourasky medical center — Tel Aviv, Israel, Israel (Recruiting)
Study contacts
- Principal investigator: Vered Kaufman-Shriqui, PhD — Ariel University
- Study coordinator: Arnon Karni, MD
- Email: arnonk@tlvmc.gov.il
- Phone: +972-52-426-6733
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.